Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6207
Source ID: NCT06709807
Associated Drug: Ckd-378 25/1000mg
Title: Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: DRUG: CKD-378 25/1000mg
Outcome Measures: Primary: AUCt of CKD-378, Area under the CKD-378 concentration in blood-time curve from 0 to t, 0, 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 24, 32, 48 hours|Cmax of CKD-378, The maximum CKD-378 concentration in blood sampling time t, 0, 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 24, 32, 48 hours |
Sponsor/Collaborators: Sponsor: Chong Kun Dang Pharmaceutical
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE1
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2024-11-08
Completion Date: 2024-12-16
Results First Posted:
Last Update Posted: 2024-11-29
Locations: H Plus Yangji Hospital, Gwanak-gu, Seoul, 08779, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT06709807